Evaluation of HER2 RNA and Protein Levels in a Large Cohort of Breast Cancer Specimens to Support Development of a Diagnostic Immunofluorescence Assay Quantified by AQUA

Jennifer Bordeaux(Lineage Cell Therapeutics (United States)), Naveen Dakappagari(Navidea Biopharmaceuticals (United States)), Mike Nerenberg(Novartis (United States)), David L. Rimm(Yale University), Krupa Chandrasekaran(Novartis (United States)), Jelveh Lameh(Lineage Cell Therapeutics (United States)), Corinne Ramos, Sue Beruti(Novartis (United States))

Unknown

January 1, 2014

Cited by 0

|Nature Reviews Clinical Oncology|2021|1.5k

|Nature|2005|1.5k

|Proceedings of the National Academy of Sciences|2009|1.4k

|JAMA Oncology|2015|834

|Laboratory Investigation|2013|753

Related Papers